Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 13,260
+260 (2.00%)
At close: Apr 21, 2025, 3:30 PM KST
KRX:271980 Revenue
In the year 2024, Jeil Pharmaceutical Co.,Ltd had annual revenue of 704.54B KRW, down -3.01%. Jeil Pharmaceutical Co.,Ltd had revenue of 186.57B in the quarter ending December 31, 2024, with 3.84% growth.
Revenue
704.54B
Revenue Growth
-3.01%
P/S Ratio
0.27
Revenue / Employee
704.54M
Employees
1,000
Market Cap
193.22B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| Peptron | 3.15B |
| LigaChem Biosciences | 125.90B |